Humanwell Healthcare (Group) Co.,Ltd. (SHA: 600079)
China
· Delayed Price · Currency is CNY
23.48
+1.06 (4.73%)
Nov 20, 2024, 3:00 PM CST
Humanwell Healthcare (Group) Co.,Ltd. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 25,477 | 24,445 | 22,276 | 20,510 | 20,598 | 21,725 | Upgrade
|
Other Revenue | 79.84 | 79.84 | 61.67 | 38.69 | 82.45 | 81.2 | Upgrade
|
Revenue | 25,556 | 24,525 | 22,338 | 20,549 | 20,680 | 21,807 | Upgrade
|
Revenue Growth (YoY) | 5.63% | 9.79% | 8.71% | -0.63% | -5.17% | 17.03% | Upgrade
|
Cost of Revenue | 13,688 | 13,302 | 12,632 | 11,777 | 12,009 | 13,195 | Upgrade
|
Gross Profit | 11,869 | 11,223 | 9,706 | 8,772 | 8,671 | 8,611 | Upgrade
|
Selling, General & Admin | 6,466 | 6,168 | 5,827 | 5,327 | 5,084 | 5,342 | Upgrade
|
Research & Development | 1,554 | 1,462 | 966.86 | 810.47 | 767.55 | 591.16 | Upgrade
|
Other Operating Expenses | 218.48 | 191.75 | 205.86 | 224.56 | 143.78 | 155.69 | Upgrade
|
Operating Expenses | 8,305 | 7,894 | 7,057 | 6,411 | 6,015 | 6,116 | Upgrade
|
Operating Income | 3,563 | 3,329 | 2,649 | 2,361 | 2,656 | 2,495 | Upgrade
|
Interest Expense | -356.4 | -354.14 | -476.57 | -602.15 | -833.6 | -851.56 | Upgrade
|
Interest & Investment Income | 150.55 | 265.56 | 978.8 | 365.38 | 376.23 | 354.88 | Upgrade
|
Currency Exchange Gain (Loss) | 45.96 | 45.96 | 123.67 | -58.34 | -100.37 | 4.72 | Upgrade
|
Other Non Operating Income (Expenses) | -385.81 | -129.77 | 120.33 | -59.2 | -169.14 | -200.73 | Upgrade
|
EBT Excluding Unusual Items | 3,018 | 3,157 | 3,395 | 2,007 | 1,929 | 1,802 | Upgrade
|
Impairment of Goodwill | -26.15 | -26.15 | -35.33 | -42.68 | -49.94 | -62.99 | Upgrade
|
Gain (Loss) on Sale of Investments | 136.85 | 136.85 | 43.42 | 7.89 | 16.4 | -9.46 | Upgrade
|
Gain (Loss) on Sale of Assets | -7.91 | -4.14 | -51.51 | 26.06 | -3.35 | -31.3 | Upgrade
|
Asset Writedown | -0.22 | -24.72 | -36.4 | -7.17 | -4.72 | -6.11 | Upgrade
|
Other Unusual Items | 145.27 | 145.27 | 110.86 | 182.16 | 139.58 | 87.18 | Upgrade
|
Pretax Income | 3,266 | 3,384 | 3,426 | 2,173 | 2,027 | 1,779 | Upgrade
|
Income Tax Expense | 626.04 | 568.56 | 354.75 | 354.78 | 385.14 | 427.96 | Upgrade
|
Earnings From Continuing Operations | 2,639 | 2,815 | 3,071 | 1,818 | 1,642 | 1,351 | Upgrade
|
Minority Interest in Earnings | -684.03 | -680.78 | -587.19 | -501.05 | -636.46 | -508.93 | Upgrade
|
Net Income | 1,955 | 2,134 | 2,484 | 1,317 | 1,006 | 842.54 | Upgrade
|
Net Income to Common | 1,955 | 2,134 | 2,484 | 1,317 | 1,006 | 842.54 | Upgrade
|
Net Income Growth | -3.58% | -14.07% | 88.60% | 30.96% | 19.37% | - | Upgrade
|
Shares Outstanding (Basic) | 1,617 | 1,617 | 1,613 | 1,587 | 1,378 | 1,453 | Upgrade
|
Shares Outstanding (Diluted) | 1,642 | 1,629 | 1,613 | 1,606 | 1,378 | 1,453 | Upgrade
|
Shares Change (YoY) | 1.27% | 1.01% | 0.42% | 16.59% | -5.16% | 11.52% | Upgrade
|
EPS (Basic) | 1.21 | 1.32 | 1.54 | 0.83 | 0.73 | 0.58 | Upgrade
|
EPS (Diluted) | 1.19 | 1.31 | 1.54 | 0.82 | 0.73 | 0.58 | Upgrade
|
EPS Growth | -4.79% | -14.94% | 87.80% | 12.33% | 25.86% | - | Upgrade
|
Free Cash Flow | 1,191 | 8.93 | -672.27 | 475.78 | 991.85 | 1,228 | Upgrade
|
Free Cash Flow Per Share | 0.73 | 0.01 | -0.42 | 0.30 | 0.72 | 0.85 | Upgrade
|
Dividend Per Share | 0.610 | 0.460 | 0.160 | 0.150 | 0.100 | 0.050 | Upgrade
|
Dividend Growth | 281.25% | 187.50% | 6.67% | 50.00% | 100.00% | - | Upgrade
|
Gross Margin | 46.44% | 45.76% | 43.45% | 42.69% | 41.93% | 39.49% | Upgrade
|
Operating Margin | 13.94% | 13.57% | 11.86% | 11.49% | 12.84% | 11.44% | Upgrade
|
Profit Margin | 7.65% | 8.70% | 11.12% | 6.41% | 4.86% | 3.86% | Upgrade
|
Free Cash Flow Margin | 4.66% | 0.04% | -3.01% | 2.32% | 4.80% | 5.63% | Upgrade
|
EBITDA | 4,235 | 4,023 | 3,372 | 3,020 | 3,337 | 3,072 | Upgrade
|
EBITDA Margin | 16.57% | 16.40% | 15.09% | 14.70% | 16.14% | 14.09% | Upgrade
|
D&A For EBITDA | 671.53 | 693.62 | 723.08 | 659.23 | 680.67 | 577.65 | Upgrade
|
EBIT | 3,563 | 3,329 | 2,649 | 2,361 | 2,656 | 2,495 | Upgrade
|
EBIT Margin | 13.94% | 13.57% | 11.86% | 11.49% | 12.84% | 11.44% | Upgrade
|
Effective Tax Rate | 19.17% | 16.80% | 10.35% | 16.33% | 19.00% | 24.05% | Upgrade
|
Revenue as Reported | 25,556 | 24,525 | 22,338 | 20,549 | 20,680 | 21,807 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.